<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04612270</url>
  </required_header>
  <id_info>
    <org_study_id>1265/2020</org_study_id>
    <nct_id>NCT04612270</nct_id>
  </id_info>
  <brief_title>Quantification of Clinically Relevant Drug Induced Changes in HbO2 Affinity</brief_title>
  <official_title>Quantification of Clinically Relevant Drug Induced Changes in HbO2 Affinity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University Innsbruck</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The presented study is an experimental in-vitro study without intervention in-vivo. The&#xD;
      effects of nitric oxide and prostacyclins, 5-hydroxymethylfurfural and alpha-ketoglutarate,&#xD;
      volatile anaesthetics on haemoglobin oxygen (HbO2) affinity will be investigated in-vitro.&#xD;
      Venous blood samples of 20 healthy young volunteers (10 female, 10 male) will be collected&#xD;
      twice in the period of one week. Informed consent will be given. Every blood collection will&#xD;
      be accompanied by a venous blood gas analysis. The blood samples will be transferred to the&#xD;
      laboratory for in-vitro recording of the complete oxygen dissociation curve (ODC). A newly&#xD;
      developed in-vitro method will be used. On the first study day the blood samples will be&#xD;
      exposed to three different concentrations of nitric oxide during the measurement, followed by&#xD;
      two different vapourized prostacyclins. In addition, different concentrations of&#xD;
      5-hydroxymethylfurfural and alpha-ketoglutarate will be given to the blood samples for ODC&#xD;
      recording. On the second study day the dose dependent effects of three different volatile&#xD;
      anaesthetics will be investigated by exposing the blood samples to these drug while the&#xD;
      measurements. Following these ODC recordings, aliquots of the blood samples will be frozen&#xD;
      and investigated for storage related changes in HbO2 affinity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 4, 2020</start_date>
  <completion_date type="Actual">June 1, 2021</completion_date>
  <primary_completion_date type="Actual">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>P50</measure>
    <time_frame>One day</time_frame>
    <description>Partial pressure of oxygen, at which 50% of haemoglobin is saturated with oxygen.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hill coefficient</measure>
    <time_frame>One day</time_frame>
    <description>Parameter describing the cooperativity of oxygen ligand binding to haemoglobin.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Oxygen Deficiency</condition>
  <arm_group>
    <arm_group_label>Participants for blood collection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The blood samples of all participants will be treated equally according to the study protocol. No intervention in-vivo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Venous blood collection</intervention_name>
    <description>Two venous blood collections in within one week. No drug-related intervention in-vivo.</description>
    <arm_group_label>Participants for blood collection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  ASA 1 (American Society of Anesthesiologists classification)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any drug intake within 10 days prior to blood collection&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Haemoglobinopathy&#xD;
&#xD;
          -  Acute inflammatory disease within 14 days prior to blood collection&#xD;
&#xD;
          -  Pregnancy or breastfeeding&#xD;
&#xD;
          -  Severe trauma or blood loss within 14 days prior to blood collection&#xD;
&#xD;
          -  Participation in any other clinical study&#xD;
&#xD;
          -  High altitude sojourn for several days (&gt; 3,000 m) within four weeks prior to blood&#xD;
             collection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>10 female and 10 male participants.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathias Str√∂hle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MUI, Department of Anaesthesiology and Critical Care Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anaesthesiology and Critical Care Medicine</name>
      <address>
        <city>Innsbruck</city>
        <state>Tyrol</state>
        <zip>6122</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 27, 2020</study_first_submitted>
  <study_first_submitted_qc>October 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2020</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

